Avid Bioservices to Exhibit at the 2016 BIO International

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Avid Bioservices to Exhibit at the 2016 BIO International Convention

TUSTIN, CA--(Marketwired - May 31, 2016) - Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc. ( NASDAQ : PPHM ) ( NASDAQ : PPHMP ), today announced that the company will exhibit at the upcoming 2016 BIO International Convention, being held June 6-9, 2016 in San Francisco. Avid will host a corporate booth (#5562) in the conference's exhibit hall where it will showcase the company's comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries, and will provide a virtual tour of Peregrine's recently-commissioned 40,000 square foot state-of-the-art commercial biomanufacturing suite, which is operated by Avid.

At the 2016 BIO International Convention, the Avid team will be able to discuss the company's innovative processes for generating a broad range of biopharmaceutical product types including monoclonal antibodies, highly-glycosylated recombinant proteins and enzymes, among others. These capabilities also extend to the manufacture of biosimiliar products and are designed to support the overall ongoing growth of the company's contract manufacturing business.

The Avid team attending the BIO International Convention will include thought-leaders in the biopharmaceutical manufacturing industry, including Pete Gagnon, the company's recently appointed vice president of process sciences. As one of the biopharmaceutical manufacturing industry's leading experts and innovators in the purification of biologics, including recombinant proteins, viruses and DNA plasmids, Mr. Gagnon has more than 30 years of manufacturing experience. During his career, he has worked collaboratively with biotechnology companies around the world to develop and optimize state-of-the-art manufacturing systems, built on the latest technologies and capabilities. 

Peregrine recently announced the formal commissioning of its new state-of-the-art commercial biomanufacturing facility in Tustin, California and cGMP production is currently underway. The facility is outfitted with cutting-edge, single-use equipment to accommodate a fully disposable biomanufacturing process for late Phase III clinical and commercial production of biologics. A range of innovative features are incorporated into the new facility including monolithic modular clean room walls, dedicated support utilities for each key processing area, and the industry's most advanced single-use production systems. Uni-directional process flows separating personnel and materials provide assurance that the design meets the most stringent regulatory requirements for commercial biologics API manufacturing. 

For more information on the BIO International Convention, please visit: http://convention.bio.org/

About Avid Bioservices Avid Bioservices provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With over 15 years of experience producing monoclonal antibodies and recombinant proteins in batch, fed-batch and perfusion modes, Avid's services include cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The company also provides a variety of process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization. For more information about Avid, please visit www.avidbio.com .

About Peregrine Pharmaceuticals, Inc. Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company developing therapeutics to stimulate the body's immune system to fight cancer. The company is focused on evaluating its lead immunotherapy candidate, bavituximab, in combination with a range of novel immuno-oncology (I-O) agents for the treatment of various cancers. One specific component of this I-O combination strategy includes a planned clinical trial of bavituximab in combination with durvalumab, AstraZeneca's investigational anti-PD-L1 immune checkpoint inhibitor, under a clinical collaboration.

In addition to its drug development programs, Peregrine also has in-house cGMP manufacturing capabilities through its wholly-owned subsidiary Avid Bioservices, Inc. ( www.avidbio.com ), which provides development and biomanufacturing services for both Peregrine and third-party customers. For more information, please visit www.peregrineinc.com .

Contacts: Kelly Pisarev Lord Avid Bioservices, Inc. (800) 987-8256 Stephanie Diaz (Investors) Vida Strategic Partners 415-675-7401 Email Contact Tim Brons (Media) Vida Strategic Partners 415-675-7402 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Older Adults Embrace Cosmetic Dentistry for Confidence

Updated Category News Views 17

Why the Shift to Cosmetic Dentistry Later in Life? Aging doesn't just wrinkle your skin; it affects your smile too. Dr. Joseph T. Sumrall and Dr. Gran Sumrall, the dental gurus of Warner Robins, Georgia, are laying out why more adults are jumping on the cosmetic dentistry bandwagon as they age. Spoiler: It ain't about getting a movie-star grin but something much deeper....

Continue Reading
CICYBELL's Black Friday Is a Fashionist's Dream

Updated Category News Views 119

Stepping Into the Fashion Frenzy It’s that time of year again, where shoppers are girding up for Black Friday. And here comes CICYBELL, ready to dish up some meaty discounts that would turn even the most hardened cynic into a frenzied shopper. Alright, maybe that’s a touch dramatic, but let’s break down what this fashion brand is cooking up in their latest sale....

Continue Reading
Dr. Obeng Joins WellcomeMD with Special Offer for Patients

Updated Category News Views 23

New Beginnings in Concierge Medicine In late October, WellcomeMD opened its doors to Dr. Paa-Kofi Obeng—an arrival greeted with considerable anticipation in Richmond's medical scene. This isn't just any run-of-the-mill staff addition; Dr. Obeng brings with him over a decade of experience from places like the Veterans Administration Medical Center. He's armed with a...

Continue Reading
Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 36

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
Mall of America Strives for World Record This Black Friday

Updated Category News Views 183

History in the Making at Mall of America Yeah, it seems these folks are not just about shopping anymore. The Mall of America is aiming to set the bar high this Black Friday, eyeing a GUINNESS WORLD RECORDS title for the most people holding up the same shopping bag all at once. Imagine a thousand people, synchronized like a flash mob—only with shopping bags instead of...

Continue Reading
LongueVue Capital: Betting Big on Sports & Entertainment

Updated Category News Views 78

LongueVue Capital's Bold Move You don’t always hear about private equity firms diving head-first into the sports and entertainment sector, but LongueVue Capital (LVC) is doing just that. This New Orleans-based firm is shifting its gears and setting sights on founder-owned ventures crucial to these industries. They’re asking the key question: Why focus on just the...

Continue Reading
Mining Equipment Market to Surge, Hitting $42.81B by 2033

Updated Category News Views 98

Forecasts on Market Growth: A Robust Climb Ahead Brace yourself because this mining equipment racket is ramping up like you wouldn't believe. Analysts are telling us the market's supposed to roar from a $28.42 billion check in 2026 to a jaw-dropping $42.81 billion come 2033. That's a 6.0% CAGR—a figure that'll catch the eye of anyone not sound asleep at the wheel....

Continue Reading
Austin Rattler Event Revamps With Two-Day Off-Road Bash

Updated Category News Views 0

Austin's Off-Road Bash Kicks Up Dust in Hill Country It's not just another grind in the biking and running world; the Life Time Austin Rattler's gone off the reservation pushing the pedals and the pace across the rugged terrain of Texas Hill Country. Here's to muscles burning and soles slapping the dirt for two straight days, all in the name of challenging nature's best....

Continue Reading
Stark Future Amasses €150M, Revving Up Electric Bike Dominance

Updated Category News Views 125

Well, if you've been keeping your eye on electric vehicles, this is a story that might raise those eyebrows. Stark Future, a name perhaps not buzzing on every street just yet, has gone and done it—snagged over €150 million in fresh capital. Breaking Barriers with Record-breaking Numbers Stark Future didn't just make a ripple; they caused a tsunami. This buzzing...

Continue Reading
Hermes AI: A New Era in Market Analysis?

Updated Category News Views 39

Revolution or Just Another App? In a world where stock market insights are as cryptic as hieroglyphs to the average Joe, here comes the Hermes AI Analyzer, breaking onto the scene and promising to translate Wall Street's complex lingo into plain, simple language. It's the brainchild of Turkish engineer Umut Tugrul, who has spent decades in the trenches of software...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking Solutions: The N-SISS Fellowship for Innovators

Updated Category News Views 146

Applications Open for the N-SISS Fellowship Innovative research incubator focused on eliminating negative health outcomes Are you a doctoral-level nurse scientist or engaged in related fields like public health and social sciences? The Institute for Policy Solutions (IPS) is thrilled to announce the opening of applications for the next cohort of the Nursing Science...

Continue Reading
Jump Global Media Expands Portfolio with Major Acquisition

Updated Category News Views 694

Jump Global Media's Strategic Acquisition Jump Global Media Group UK Ltd. (Jump GMG), a leading multi-platform entertainment company, has made a significant move in the film and television industry by acquiring the rights to The Empress and I, a compelling memoir penned by renowned author Donna Stein. The Story Behind the Memoir The Empress and I narrates an extraordinary...

Continue Reading
VIVO Agency Welcomes Jennifer Mugnaini as New EVP of Services

Updated Category News Views 126

VIVO Agency Appoints Jennifer Mugnaini as EVP of Client Services Strategically enhancing client leadership and driving growth, VIVO Agency has named Jennifer Mugnaini as the new Executive Vice President of Client Services. With more than twenty years of extensive experience in healthcare and MedTech marketing, Jen is poised to elevate the agency's client service teams,...

Continue Reading
IMU Biosciences Welcomes Dr. Carlos Paya to Its Board

Updated Category News Views 197

IMU Biosciences Welcomes Dr. Carlos Paya as Non-Executive Director IMU Biosciences, a pioneering biotechnology company focused on innovating how the immune system is understood and treated, has recently bolstered its leadership team. The company is thrilled to announce the appointment of Dr. Carlos Paya as a Non-Executive Director. His extensive experience in both...

Continue Reading
Significant Impact of Older Voters in Pittsburgh's Future

Updated Category News Views 225

Older Voters in Pittsburgh: A Key Factor in the Upcoming Election In the vibrant city of Pittsburgh, voters aged 50 and older are gearing up to play a crucial role in the next mayoral election. Recent insights reveal that this demographic not only makes up a substantial percentage of the voting public, but they are also highly engaged on critical issues that impact their...

Continue Reading